TITLE

Soft contact lens wear significantly influences peripheral vision

AUTHOR(S)
Hasson, Matt
PUB. DATE
August 2010
SOURCE
Ocular Surgery News;8/10/2010, Vol. 28 Issue 15, p8
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses a study which investigated the effect of soft contact lens wear on peripheral vision presented by Doctor Asaki Suzaki and colleagues at the Association for Research in Vision and Ophthalmology in Fort Lauderdale, Florida. Thirty eyes of 15 patients fitted with spherical soft contact lenses wit powers of plano, -3 D and -7 D were analyzed by the researchers.
ACCESSION #
52543758

 

Related Articles

  • Visionary genomics focus of 2011 ARVO meeting. Olson, Joanne // Ophthalmology Times;10/15/2010, Vol. 35 Issue 20, p18 

    The article offers information on the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) on May 1 to 5, 2011 to be held in Fort Lauderdale, Florida.

  • Promedior Announces Presentation of Data at ARVO Demonstrating that Pentraxin-2 Suppresses Fibrosis, Neovascularization, and Vascular Leak in Retinal Disease Models.  // Biomedical Market Newsletter;5/5/2012, Vol. 21, p1 

    The article offers information on the Association for Research in Vision and Ophthalmology's annual meeting on treatment of fibroproliferative diseases to be held in Fort Lauderdale, Florida from May 6-10, 2012.

  • ARVO meeting to feature career resources, workshops. Tibbetts, Elinore L. // Ophthalmology Times;2/15/2007, Vol. 32 Issue 4, p22 

    The article offers information on the annual meeting of the Association for Research in Vision and Ophthalmology (AVRO), to be held on May 6-10, 2007 in Fort Lauderdale, Florida, and the Asia-AVRO meeting, to be held on March 2-5, 2007 in Singapore.

  • ARVO Brandishes The Cutting Edge. Abelson, Mark B. // Review of Ophthalmology;Jul2009 Part 1 of 2, Vol. 16 Issue 7, p44 

    Information on the Annual for Research in Vision and Ophthalmology (ARVO) 2009 in Fort Lauderdale, Florida is presented. The event highlights science research and clinical investigations of novel therapeutics for diabetic retinopathy, dry eye and lid-margin disease of inflammation and allergy....

  • Glaucoma factors still under study. Charters, Lynda // Ophthalmology Times;8/1/2011, Vol. 36 Issue 15, p16 

    Information about the topics discussed at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) held in Fort Lauderdale, Florida is presented. It highlights the presentation of Dr. Mark W. Johnson regarding the insignificance of adjuvant scleral buckling and...

  • Aflibercept promising in CRVO. Groves, Nancy // Ophthalmology Times;8/1/2011, Vol. 36 Issue 15, p18 

    Information about the topics discussed at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) held in Fort Lauderdale, Florida is presented. It highlights the presentation of the phase III Copernicus study that confirms the 56.1% of the patients who received...

  • Subretinal implant provides stable percepts synchronized with eye movement. Hasson, Matt // Ocular Surgery News;8/10/2010, Vol. 28 Issue 15, p24 

    The article reports on a subretinal electronic implant with a light-sensitive chip that provided stable visual images tracking objects with regular eye movement. Information on the implant was provided by Doctor Eberhart Zrenner during the Association for Research in Vision and Opthalmology...

  • Corneal graft manipulation spurs endothelial cell loss. Hasson, Matt // Ocular Surgery News;8/10/2010, Vol. 28 Issue 15, p25 

    The article reports on the risk of endothelial damage in Descemet stripping automated endothelial keratoplasty (DSAEK) posed by the manipulation of graft tissue. Research with two common tissue insertion devices was presented by Doctor Mark A. Terry at the Association for Research in Vision and...

  • Pegaptanib shows promise as adjunct to PDR treatment. Petrou, Ilya // Ophthalmology Times;8/1/2008, Vol. 33 Issue 15, p18 

    The article focuses on the study of the significance and usefulness of pegaptanib sodium in treating proliferative diabetic retinopathy (DPR) in Fort Lauderdale, Florida. The clinical findings of the therapeutic drug is presented at the annual meeting of the Association for Research in Vision...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics